Polysaccharide Storage Myopathy (PSSM)

Polysaccharide Storage Myopathy (PSSM) is an inherited muscle disorder in horses characterized by abnormal accumulation of glycogen and abnormal polysaccharide within skeletal muscle cells, leading to muscle dysfunction, pain, and exercise intolerance. This condition occurs when muscle cells store excessive amounts of sugar-based molecules that they cannot properly utilize for energy production during exercise. The accumulated material interferes with normal muscle function and can cause symptoms ranging from mild stiffness after exercise to severe episodes of muscle cramping and breakdown that temporarily incapacitate affected horses.

PSSM is now recognized as encompassing at least two distinct forms with different genetic bases. PSSM type 1 (PSSM1) results from a specific mutation in the glycogen synthase 1 (GYS1) gene and can be definitively diagnosed through genetic testing. PSSM type 2 (PSSM2) describes horses with similar clinical signs and muscle biopsy findings but without the GYS1 mutation; the genetic causes of PSSM2 are still being investigated, with multiple genes potentially involved. Both types cause similar clinical problems, though some evidence suggests they may respond somewhat differently to management approaches.

The prevalence of PSSM varies significantly among horse breeds, with certain populations showing remarkably high carrier rates. Studies have found that over 10 percent of Quarter Horses carry the PSSM1 mutation, with even higher rates in certain bloodlines, particularly those bred for halter competition and western pleasure. Draft breeds including Belgians, Percherons, and Clydesdales show similarly high prevalence. Warmbloods carry risk through their draft breed ancestry. Understanding breed-specific risk helps owners and veterinarians maintain appropriate awareness for early detection in susceptible populations.

The impact of PSSM on horses can range from minimal to significant depending on individual severity and how well the condition is managed. With appropriate diet and exercise protocols, many PSSM horses perform well in athletic careers across various disciplines. However, unmanaged or poorly managed cases experience recurrent episodes of muscle pain and tying-up that can significantly impair quality of life and athletic function. Early diagnosis and consistent implementation of appropriate management strategies offer the best opportunity for affected horses to thrive despite their genetic condition.

The primary cause of PSSM type 1 is a specific missense mutation in the glycogen synthase 1 (GYS1) gene located on equine chromosome 10. This mutation results in a gain-of-function change that makes the glycogen synthase enzyme abnormally active, causing muscle cells to produce and store excessive amounts of glycogen. Additionally, the mutation leads to production of an abnormal polysaccharide that accumulates within muscle fibers and cannot be properly broken down. This accumulated material interferes with normal muscle cell function and energy production during exercise, leading to the clinical signs associated with the condition.

The genetic inheritance of PSSM1 follows an autosomal dominant pattern, meaning that horses carrying just one copy of the mutated gene (heterozygous) can develop clinical disease. Horses with two copies of the mutation (homozygous) are typically more severely affected. Because the condition is dominant, affected horses have a 50 percent chance of passing the mutation to offspring when bred to unaffected horses. This inheritance pattern explains how the mutation has become prevalent in certain breed populations despite causing clinical problems, as heterozygous horses may perform adequately or show only mild signs easily attributed to other causes.

PSSM type 2 represents horses with clinical and histopathological findings consistent with polysaccharide storage myopathy but without the GYS1 mutation. The genetic causes of PSSM2 remain under investigation, with research suggesting involvement of multiple genes potentially including those affecting muscle fiber structure or metabolism through mechanisms different from PSSM1. Several candidate gene variants have been identified, though none have achieved the definitive status of the GYS1 mutation for PSSM1. PSSM2 appears to be more common in breeds with athletic rather than stock or draft backgrounds, including Warmbloods, Arabians, and Morgans.

Environmental and management factors significantly influence whether horses with PSSM genetic predisposition develop clinical problems and how severe episodes become. Diet composition is critical, as high-starch feeds provide substrate for excessive glycogen synthesis. Exercise patterns profoundly affect episode risk, with intermittent intense work following rest periods being particularly problematic. Stress from transportation, illness, or environmental changes can trigger episodes. Weather conditions, particularly cold temperatures, may increase stiffness. These modifiable factors explain why management changes can so effectively reduce clinical signs despite the underlying genetic condition remaining unchanged.

The pathophysiology of PSSM involves disruption of normal muscle energy metabolism. During exercise, muscles normally break down stored glycogen to generate ATP for contraction. In PSSM horses, the abnormal glycogen and polysaccharide cannot be efficiently utilized, creating energy deficits within working muscle cells. The accumulated material may also directly interfere with cellular function. When metabolic demand exceeds the cell's compromised capacity, muscle fiber damage occurs, releasing intracellular contents including creatine kinase and myoglobin into circulation. Severe episodes with extensive fiber damage constitute rhabdomyolysis, with potential complications including myoglobin-induced kidney damage.

Early warning signs of PSSM may be present long before owners recognize a significant problem, as horses compensate for mild discomfort and owners attribute subtle changes to other causes. Horses may show reluctance to work, particularly during the first several minutes of exercise before muscles warm up. Mild hindquarter stiffness or shortened stride that improves with continued movement is characteristic. Some horses develop behavioral changes including resistance to being caught, reluctance to accept the saddle, or attitude changes suggesting discomfort. Difficulty engaging the hindquarters for collection or impulsion may be noticed in trained horses. These early signs warrant investigation, as identifying PSSM before severe episodes occur allows preventive management.

Common symptoms of PSSM during clinical episodes include obvious muscle stiffness and cramping, particularly affecting the large hindquarter muscles including the gluteals and semimembranosus/semitendinosus muscles. Affected horses display shortened, stiff stride and may refuse to move forward. The hindquarter muscles often feel firm or hard to the touch due to sustained contraction. Excessive sweating disproportionate to work level commonly accompanies muscle pain. Horses may show signs of distress including anxious expression, elevated heart rate, and increased respiratory rate. Some horses attempt to stretch or posture to relieve discomfort, while others become reluctant to change position.

Behavioral changes during PSSM episodes reflect the horse's pain and may mimic other conditions. Affected horses often become anxious and restless, pawing or shifting weight frequently. Some horses look at their flanks or attempt to lie down, behaviors also associated with colic. Appetite typically decreases during and immediately after episodes. Some horses become reluctant to lie down, possibly because rising is uncomfortable. Between episodes, horses with poorly managed PSSM may develop persistent behavioral changes including sourness, resistance to work, or general irritability reflecting chronic low-grade discomfort.

Physical signs of PSSM extend beyond the obvious muscle symptoms. During severe episodes, muscle swelling may be visible, particularly in the hindquarters and back. The muscles feel abnormally firm due to sustained contraction and developing inflammation. Dark brown or red-tinged urine (myoglobinuria) indicates significant muscle breakdown and represents a serious sign requiring veterinary attention. Some horses develop muscle atrophy over time if the condition remains poorly controlled, as repeated damage and inadequate regeneration lead to loss of functional muscle mass. Skin twitching or fasciculations over affected muscles may be observed in some horses.

Symptom progression in PSSM typically correlates with exercise intensity and duration, though individual variation exists. Mild cases show only slight stiffness during the first minutes of work that resolves with continued exercise. Moderate episodes cause obvious lameness and muscle discomfort but resolve with rest within hours to days. Severe episodes feature extreme muscle cramping preventing normal movement, significant myoglobinuria, and require veterinary intervention. Without appropriate management changes, horses often experience escalating episode severity and frequency over time. Some horses have relatively consistent episode patterns, while others vary considerably in presentation.

Emergency symptoms requiring immediate veterinary attention include severe muscle cramping preventing normal movement or causing the horse to be unable to walk, dark discolored urine indicating significant muscle breakdown, extreme distress or pain behaviors, inability to rise after lying down, colic signs that might indicate developing kidney problems, or any sign of shock including pale mucous membranes, rapid weak pulse, or cold extremities. Severe rhabdomyolysis is a medical emergency requiring aggressive fluid therapy to prevent kidney damage from myoglobin. Even moderate episodes warrant veterinary consultation to assess severity, initiate appropriate treatment, and develop management plans.

Physical examination findings in horses with suspected PSSM include assessment of body condition, muscle development and symmetry, and evaluation of gait and posture. During or shortly after episodes, affected horses display muscle stiffness, shortened stride, and reluctance to move freely. Palpation reveals firm, painful muscles particularly in the hindquarters and back. Heart rate and respiratory rate are often elevated reflecting pain and stress. Between episodes, examination may be relatively normal, though some horses show subtle muscle asymmetry, general muscle sensitivity, or reluctance during certain movements. Physical examination helps characterize episode severity and guides treatment decisions.

Genetic testing has become the primary diagnostic tool for PSSM type 1, offering a definitive, non-invasive diagnosis through hair root or blood samples. The test identifies the GYS1 mutation with high accuracy, distinguishing between horses with no copies (N/N, normal), one copy (N/P, heterozygous carrier), or two copies (P/P, homozygous affected) of the mutation. This testing can be performed on horses of any age, including foals, allowing early identification before training begins. Genetic testing is commercially available through multiple laboratories and is relatively affordable, making it accessible for routine screening in at-risk breeds.

Muscle biopsy remains important for diagnosing PSSM type 2 and confirming PSSM1 in uncertain cases. The biopsy procedure involves collecting small samples from the semimembranosus or gluteal muscles under local anesthesia. Histopathological examination reveals the characteristic abnormal polysaccharide accumulations that appear as dark-staining deposits with periodic acid-Schiff (PAS) staining that resist digestion with amylase. Muscle biopsy can also identify other myopathies that might be present concurrently or that need to be distinguished from PSSM. The procedure is generally well-tolerated but is more invasive and expensive than genetic testing.

Additional diagnostic testing supports PSSM diagnosis and management. Blood work evaluating muscle enzyme levels (CK and AST) identifies active muscle damage and helps assess episode severity. Resting enzyme elevations in horses not recently exercised suggest ongoing muscle problems. Urinalysis can detect myoglobin, confirming significant rhabdomyolysis and helping assess kidney risk. Exercise challenge tests under controlled conditions may reveal abnormal enzyme responses to exertion in horses with subtle presentations. Electromyography can identify abnormal muscle electrical activity. Differential diagnosis includes ruling out other causes of recurrent muscle problems including nutritional myopathy, immune-mediated myositis, and various other myopathies with similar clinical presentations.

Emergency and immediate treatment for acute PSSM episodes focuses on stopping exercise, relieving pain, and preventing kidney damage from myoglobin. Exercise must cease immediately when episode signs are recognized, as continued work dramatically worsens muscle damage. The horse should be kept calm and allowed to rest; if walking is necessary for transport, it should be slow and only for short distances. Veterinary attention is sought promptly for moderate to severe episodes. Intravenous fluid therapy is the cornerstone of treatment for significant rhabdomyolysis, maintaining kidney perfusion and promoting myoglobin excretion. Non-steroidal anti-inflammatory drugs provide pain relief.

Dietary management is the cornerstone of long-term PSSM treatment and often produces dramatic improvement in clinical signs. The fundamental dietary change involves switching from high-starch feeds to a low-starch, high-fat diet. Traditional grain-based concentrates are eliminated, replaced with feeds containing less than 10 to 12 percent non-structural carbohydrates (NSC). Fat becomes the primary supplemental energy source, typically providing 13 to 20 percent of total calories through added oil, rice bran, or commercial high-fat feeds. Forage should be low-sugar hay, ideally tested to confirm NSC content below 12 percent. This dietary approach reduces substrate for abnormal glycogen accumulation while providing adequate energy through fat metabolism.

Exercise management complements dietary changes as the second pillar of PSSM treatment. Regular, consistent exercise improves muscle metabolism and reduces episode risk more effectively than sporadic work. Daily exercise is recommended whenever possible, even if only light activity such as turnout, lunging, or hand-walking. Extended warm-up periods of 15 to 30 minutes at walk allow muscles to gradually transition to fat-based metabolism before demanding work. Avoiding the pattern of rest followed by sudden intense work is critical, as this consistently triggers episodes in susceptible horses. Some horses benefit from light exercise even on days without formal training sessions.

Supportive care measures complement the primary diet and exercise protocols. Vitamin E supplementation supports muscle cell membrane stability and is commonly recommended at 1,000 to 2,000 IU daily. Selenium supplementation may be appropriate in deficient areas but should be based on blood testing to avoid toxicity. Adequate water and salt availability supports hydration and electrolyte balance. Turnout rather than stall confinement promotes continuous low-level movement beneficial for PSSM horses. Management of stress, including minimizing transportation, competition pressure, and environmental changes when possible, reduces episode triggers.

Rehabilitation after PSSM episodes follows the general principle of gradual return to exercise once acute inflammation resolves and muscle enzymes normalize. Hand-walking begins within a few days of episode resolution for mild to moderate cases, gradually increasing duration over one to two weeks. Light ridden or driven work resumes when the horse moves comfortably and enzyme levels have returned to baseline. Exercise intensity and duration increase gradually over several weeks to months. Throughout rehabilitation and beyond, the dietary changes and exercise consistency remain permanent requirements; PSSM is managed, not cured, and returning to previous feeding and exercise patterns will cause symptom recurrence.

Treatment decision factors include whether the horse has PSSM1, PSSM2, or both, as some evidence suggests response to management may vary somewhat between types. Episode severity and frequency influence treatment intensity and monitoring requirements. The horse's intended use affects exercise protocol details, though the fundamental principles apply regardless of discipline. Practical considerations including facility capabilities, feed availability, and owner resources affect implementation of ideal protocols. Genetic counseling should be provided for breeding stock regarding inheritance patterns and offspring risk.

Recovery timelines from PSSM episodes depend on episode severity and how quickly appropriate management is implemented. Mild episodes with minimal enzyme elevation may resolve within one to three days with rest and symptomatic treatment. Moderate episodes typically require five to ten days before return to exercise is appropriate. Severe rhabdomyolysis with significant myoglobinuria may require two to four weeks or longer for complete recovery, with kidney function monitored throughout. These timelines represent recovery from individual episodes; achieving optimal long-term control through diet and exercise changes requires consistent implementation over months.

Post-treatment care following PSSM episodes involves implementing the dietary and exercise changes that will prevent future episodes. Dietary transition to low-starch, high-fat feeding should begin immediately and be completed over one to two weeks to allow digestive adaptation. Exercise begins conservatively and builds gradually as the horse demonstrates comfortable movement and normal muscle enzyme levels. Monitoring for signs of recurrence during the transition period allows adjustment of management if needed. Follow-up veterinary consultation confirms appropriate response to management and provides guidance for ongoing care.

Prognosis factors influencing long-term outcomes with PSSM include the horse's specific genetic status (homozygous horses may be more severely affected), individual response to dietary and exercise management, owner compliance with management protocols, and the horse's intended use. Most horses with PSSM respond well to appropriate management and can maintain athletic careers, though some require ongoing fine-tuning of their programs. Horses that do not respond adequately to standard management may have concurrent conditions or need additional diagnostic investigation. Early diagnosis and consistent management optimize long-term outcomes.

Long-term outlook for horses with PSSM is generally favorable with appropriate management. Many horses experience complete resolution of clinical signs and perform at high levels across various disciplines including racing, eventing, dressage, and western performance. The condition is lifelong and requires permanent management commitment, but the investment typically produces good results. Some horses remain prone to occasional episodes despite good management, particularly during stressful situations, but these are usually mild when underlying management is appropriate. Quality of life for well-managed PSSM horses is typically excellent, and many owners report dramatic improvement in their horses' attitudes and performance once proper diet and exercise protocols are implemented.

Management practices for preventing PSSM episodes in diagnosed horses center on consistent implementation of appropriate diet and exercise protocols. Regular daily exercise maintains muscle metabolism in a state less prone to episodes, with consistency being more important than intensity. Avoiding extended rest periods followed by sudden work demands prevents the most common trigger for episodes. Maintaining consistent routines minimizes stress that might precipitate problems. Planning ahead for situations requiring reduced exercise, such as injury recovery or severe weather, allows gradual rather than sudden work reductions and resumptions.

Nutritional prevention through appropriate diet forms the foundation of PSSM management. Selecting feeds specifically formulated for PSSM horses or creating appropriate rations from suitable ingredients ensures consistent low-starch intake. Testing hay for NSC content identifies suitable forage sources. Avoiding treats and supplements containing hidden sugars or starches prevents inadvertent dietary lapses. Maintaining appropriate body condition without excess weight supports overall metabolic health. Feeding schedules that provide consistent energy intake throughout the day, rather than large meals, may benefit some horses.

Exercise and conditioning strategies for PSSM prevention emphasize regularity and appropriate preparation for work. Daily exercise, even if only turnout in a large area, maintains beneficial metabolic adaptations. Extended warm-up periods of walking and light trot prepare muscles for more demanding work. Fitness appropriate to planned workload reduces the risk of metabolic demand exceeding capacity. Gradual increases in training intensity allow adaptation. Planning training schedules to maintain consistency, including light work on rest days rather than complete inactivity, optimizes prevention.

Environmental factors affecting PSSM include temperature, with cold weather potentially increasing muscle stiffness and episode risk in some horses. Adequate shelter and appropriate blanketing maintain muscle warmth. Minimizing transportation stress through careful planning, allowing rest periods, and ensuring adequate hydration protects against travel-associated episodes. Reducing competition and environmental stress when possible, or providing additional management support during stressful periods, helps prevent stress-triggered problems. Maintaining stable social groups and living situations reduces psychological stress.

Genetic testing and breeding recommendations for PSSM include testing all breeding stock from at-risk breeds to identify carriers. Informed breeding decisions can reduce PSSM prevalence in future generations by avoiding mating two carriers, which produces 25 percent homozygous affected offspring. However, many heterozygous carriers perform well with appropriate management, and overly restrictive breeding policies could unnecessarily limit breed gene pools. Potential buyers of breeds with high PSSM prevalence should consider genetic testing before purchase. Pre-purchase examinations for horses in at-risk breeds should include discussion of PSSM testing options.

Daily management for horses with PSSM incorporates condition-specific protocols into routine care. Consistent feeding of the prescribed low-starch, high-fat diet at regular times supports stable metabolism. Daily exercise appropriate to the individual horse maintains beneficial adaptations; this might be formal training, lunging, or simply turnout in adequate space for self-exercise. Brief daily assessment noting attitude, movement quality, and any stiffness identifies developing problems early. Record keeping of diet, exercise, and observations helps identify patterns and refine management over time. Communication with veterinarians and other care providers ensures consistent approach across all aspects of management.

Housing and turnout considerations for PSSM horses strongly favor maximum turnout whenever safely possible. Continuous low-level movement during turnout maintains muscle metabolism better than stall confinement interrupted by exercise sessions. Large pastures or paddocks allowing free movement are ideal. Group turnout with compatible horses encourages activity through social interaction. When stall confinement is necessary, the duration should be minimized and compensated with additional structured exercise. Climate control through adequate shelter and appropriate blanketing maintains muscle comfort, particularly during cold weather when stiffness may increase.

Exercise modifications for PSSM horses apply general principles while accommodating individual needs. Consistent daily exercise is paramount, with the specific type and intensity matched to the horse's fitness level and intended use. Extended warm-up of 15 to 30 minutes of walking allows gradual metabolic transition before demanding work. Training schedules maintain regularity, avoiding the rest-followed-by-intense-work pattern that triggers episodes. Light work on nominally rest days provides better outcomes than complete inactivity. Flexibility allows adjustment for weather, individual horse condition on given days, and recognition of early warning signs that might warrant reduced work.

Monitoring and ongoing care for PSSM horses includes regular veterinary evaluation, typically annually or semi-annually for stable horses, with additional consultation if problems develop. Periodic muscle enzyme testing confirms management effectiveness. Body condition monitoring ensures diet provides appropriate calories. Observation of movement quality, attitude, and performance identifies subtle changes warranting attention. Adjustments to management may be needed seasonally, with changes in workload, or as the horse ages. Maintaining communication with veterinary professionals ensures appropriate response to any changes in the horse's condition.

Quality of life and use considerations for PSSM horses are generally positive with appropriate management. Most horses achieve excellent quality of life and maintain athletic careers across diverse disciplines. Their needs require owner commitment to consistent diet and exercise protocols, but the investment typically produces rewarding results. Some horses require ongoing fine-tuning of their management, and occasional mild episodes may occur despite good management. Career changes to less demanding work are occasionally necessary for horses that prove difficult to manage effectively, but this is the exception rather than the rule. Well-managed PSSM horses often perform as well or better than before diagnosis, as owners become more attuned to their individual needs.

Quarter Horses and related breeds show the highest prevalence of PSSM type 1, with studies finding the GYS1 mutation in more than 10 percent of the overall Quarter Horse population. Certain bloodlines, particularly those bred for halter conformation and western pleasure, show even higher prevalence rates exceeding 20 to 30 percent in some samples. Paint Horses and Appaloosas, which share Quarter Horse ancestry, carry similar risk. The wide distribution of the mutation across these popular breeds makes PSSM awareness essential for owners, breeders, and veterinarians working with stock horse populations. The relatively high frequency of the mutation suggests it may have provided some selective advantage historically, possibly related to easy keeping or muscle mass development.

Draft breeds including Belgians, Percherons, Clydesdales, and related populations carry PSSM1 prevalence comparable to or exceeding Quarter Horses. Studies have found the mutation in 36 to 50 percent of some draft breed populations. Warmbloods have intermediate risk through their draft breed ancestry, with prevalence varying based on the specific breeds in their backgrounds. Draft crosses used for sporthorse breeding may introduce PSSM risk into populations not traditionally associated with the condition. The heavy muscling characteristic of draft breeds may make PSSM symptoms more severe when they occur.

PSSM type 2, which lacks the GYS1 mutation but produces similar clinical findings, appears more common in light horse breeds including Arabians, Morgans, and Thoroughbreds, as well as Warmbloods. The genetic bases for PSSM2 are still being investigated, and prevalence data are less well-established than for PSSM1. Genetic testing for PSSM2-associated variants is available but less definitive than PSSM1 testing. Breeding recommendations for PSSM1 are straightforward given the known inheritance pattern, while PSSM2 breeding decisions are more complex given the incomplete understanding of its genetics. Testing breeding stock from all breeds with significant PSSM prevalence enables informed decisions regardless of the specific type.

Commonly co-occurring conditions with PSSM include other muscle disorders that may share genetic links or management considerations. Some horses have both PSSM1 and myofibrillar myopathy or other PSSM2-associated changes simultaneously. Horses with PSSM may have concurrent immune-mediated myositis, particularly in Quarter Horse populations where both conditions are prevalent. Equine metabolic syndrome shares some features with PSSM including insulin dysregulation and may influence management approaches. Shivers, a movement disorder particularly common in draft breeds, may be associated with PSSM, though the relationship remains incompletely understood. Recognizing potential concurrent conditions ensures comprehensive diagnosis and management.

Conditions with similar symptoms that must be differentiated from PSSM include other forms of exertional rhabdomyolysis without identified genetic cause, which may respond to different management approaches. Immune-mediated myositis causes muscle problems in Quarter Horses but requires immunosuppressive rather than dietary treatment. Nutritional myopathy from vitamin E or selenium deficiency presents similarly but responds to supplementation. Malignant hyperthermia susceptibility, caused by a different genetic mutation, triggers episodes under different circumstances. Back pain from various causes may present with stiffness and reluctance to work. Accurate diagnosis through appropriate testing ensures correct management.

Potential complications of PSSM include kidney damage from myoglobin nephrotoxicity during severe rhabdomyolysis episodes, which can be life-threatening if not treated promptly with aggressive fluid therapy. Repeated episodes cause cumulative muscle damage potentially leading to permanent atrophy and weakness. Secondary musculoskeletal problems may develop from altered movement patterns during episodes or chronic low-grade discomfort. Behavioral changes from chronic pain affect quality of life and human-horse relationships. Career-ending disability occurs in some horses with severe or poorly managed disease. Appropriate ongoing management minimizes these risks and optimizes long-term outcomes for affected horses.